- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 5, 2026 | 9.38M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 9.38M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 2.58M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$5.86M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$7.69M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $5.13M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $10.08M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $19.85M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $20.73M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $14.51M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $20.95M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | −$100.63M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | −$91.13M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $11.26M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $11.04M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $11.31M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $11.13M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $25.33M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $31.54M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $25.82M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $32.07M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.73 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$3.72 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.73 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$3.72 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.14M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $1.24M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $4.91M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $3.11M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.8M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$9.58M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$7.05M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$4.35M |